Concern-driven integrated approaches to nanomaterial testing and assessment-report of the NanoSafety Cluster Working Group 10

Nanotoxicology

Volumn 8, Issue 3, 2014, Pages 334-348

  Oomen, Agnes G ^a   Bos, Peter M J ^a   Fernandes, Teresa F ^b   Hund Rinke, Kerstin ^c   Boraschi, Diana ^d   Byrne, Hugh J ^e   Aschberger, Karin ^f   Gottardo, Stefania ^f   Von Der Kammer, Frank ^g   Kühnel, Dana ^h   Hristozov, Danail ⁱ   Marcomini, Antonio ⁱ   Migliore, Lucia ^j   Scott Fordsmand, Janeck ^k   Wick, Peter ^l   Landsiedel, Robert ^m  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^d CNR   (Italy)

^e DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^f JOINT RESEARCH CENTRE   (Italy)

^g UNIVERSITY OF VIENNA   (Austria)

^h HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

ⁱ CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^j UNIVERSITY OF PISA   (Italy)

^k AARHUS UNIVERSITY   (Denmark)

^l SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

^m BASF SE   (Germany)

more..

Author keywords

3Rs principle; Environmental hazard assessment; Grouping of substances; Human health hazard assessment; Nanotoxicology

Indexed keywords

NANOMATERIAL;

ARTICLE; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; CARDIOTOXICITY; DEVELOPMENTAL TOXICITY; DISPERSION; ECOTOXICITY; ENVIRONMENTAL IMPACT; EUROPEAN UNION; EXPOSURE; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; NEUROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; TOXICITY TESTING;

ANIMALS; CELL LINE; EUROPEAN UNION; HUMANS; NANOSTRUCTURES; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84890385124     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.802387     Document Type: Article

References (77)

1. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Env Toxicol Chem 29:730-741
2. Anon. 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/ EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396/1, 30 December 2006
3. Anon. 2008. Directive 2008/105/EC of the European Parliament and of the Council of 16 December 2008 on environmental quality standards in the field of water policy, amending and subsequently repealing Council Directives 82/176/EEC, 83/513/EEC, 84/156/ EEC, 84/491/EEC, 86/280/EEC and amending Directive 2000/60/ EC of the European Parliament and of the Council. OJ L 348/84, 24 December 2008
4. Anon. 2010a. Communication from the Commission. Europe 2020 - A European strategy for smart, sustainable and inclusive growth. COM(2010)2020. Brussels, 3 March 2010. 37http://ec. europa.eu/research/era/docs/en/investing-in-research- europeancommission- europe-2020-2010.pdf
5. Anon. 2010b. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. O.J. L 276/33, 20 October 2010
6. Anon. 2011a. Proposal for a regulation of the European Parliament and of the Council establishing Horizon 2020 - The Framework Programme for Research and Innovation (2014 - 2020). COM(2011) 809 final, Brussels, 30 November 2011. http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=COM:2011:0809:FIN:en:PDF
7. Anon. 2011b. Commission recommendation on the definition of nanomaterial. OJ L 275/38, 18 October 2011
8. Anon. 2012a. Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Second regulatory review on nanomaterials. COM (2012)572 final. Brussels, 3 October 2012. http://eur-lex.europa. eu/LexUriServ/LexUriServ.do?uri=COM:2012:0572:FIN: en:PDF
9. Anon. 2012b. Commission staff working paper. Types and uses of nanomaterials, including safety aspects; accompanying the Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee on the Second Regulatory Review on Nanomaterials (COM(2012) 572 final. SWD(2012) 288 final. Brussels, 3 October 2012. 111http:// eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2012:0288: FIN:EN:PDF
10. Aschberger K, Micheletti C, Sokull-Klüttgen B, Christensen FM. 2011 Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health - lessons learned from four case studies. Environ Int 37(6):1143-1156
11. Becker H, Herzberg F, Schulte A, Kolossa-Gehring M. 2011. The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int J Hygiene Environ Health 214 (3):231-238
12. Bhattacharya K, Naha PC, Naydenova I, Mintova S, Byrne HJ. 2012. Reactive oxygen species mediated DNA damage in human lung alveolar epithelial (A549) cells from exposure to non-cytotoxic MFItype zeolite nanoparticles. Toxicol Lett 215(3):151-160
13. Bleeker EA, de Jong WH, Geertsma RE, Groenewold M, Heugens EH, Koers-Jacquemijns M, et al. 2013. Considerations on the EU definition of a nanomaterial: Science to support policy making. Regul Toxicol Pharmacol 65(1):119-125
14. Boraschi D, Costantino L, Italiani P. 2012. Interaction of nanoparticles with immunocompetent cells: Nanosafety considerations. Nanomed 7(1):121-131
15. Burlinson B. 2012. The in vitro and in vivo Comet assays. Methods Mol Biol 817:143-163
16. Card JW, Magnuson BA. 2009. Letter to the Editor. J Food Sci 74:vi-vii. doi: 10.1111/j.1750-3841.2009.01366.x.
17. Card JW, Magnuson BA. 2010. A method to assess the quality of studies that examine the toxicity of engineered nanomaterials. Int J Toxicol 29(4):402-410
18. Cheng JB, Cho RJ. 2012. Genetics and epigenetics of the skin meet deep sequence. J Invest Dermatol 132(3 Pt 2):923-932
19. Cockburn A, Bradford R, Buck N, Constable A, Edwards G, Haber B, et al. 2012. Approaches to the safety assessment of engineered nanomaterials (ENM) in food. Food Chem Toxicol 50 (6):2224-2242
20. Colognato R, Coppedè F, Ponti J, Sabbioni E, Migliore L. 2007. Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay. Mutagenesis 22(4):255-261
21. Dan M, Wu P, Grulke EA, Graham UM, Unrine JM, Yokel RA. 2012. Ceria engineered nanomaterial distribution in and clearance from blood: Size matters. Nanomed 7(1):95-110
22. Dekkers S, Bouwmeester H, Bos PMJ, Peters RJB, Rietveld AG, Oomen AG. 2012. Knowledge gaps in risk assessment of nanosilica in food: Evaluation of the dissolution and toxicity of different forms of silica. Nanotoxicology Epub ahead of print; doi: 10.3109,17435390.2012.662250
23. Dekkers S, Krystek P, Peters RJB, Lankveld DPK, Bokkers BGH, van Hoeven-Arentzen PH, et al. 2011. Presence and risks of nanosilica in food products. Nanotoxicology 5(3):393-405
24. ECHA. 2012. European Chemicals Agency - Guidance on information requirements and chemical safety assessment. Appendix R7-1
25. Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific guidance. ECHA; 12-G-03-EN. EFSA. 2011. European Food Safety Authority - Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J 9(5):2140
26. Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2(5):1084-1104
27. Firestone M, Kavlock R, Zenick H, Kramer M; US Environmental Protection Agency Working Group on the Future of Toxicity Testing. 2010. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals. J Toxicol Environ Health B Crit Rev 13(2-4):139-162
28. Gasser M, Rothen-Rutishauser B, Krug HF, Gehr P, Nelle M, Yan B, et al. 2010. Lipids of the pulmonary surfactant and functional groups on multi-walled carbon nanotubes influence blood plasma proteins adsorption differently. J Nanobiotech 8:31
29. Handy RD, Cornelis G, Fernandes TF, Tsyusko O, Decho A, Sabo-Attwood T, et al. 2012b. Ecotoxicity test methods for engineered nanomaterials: Practical experiences and recommendations from the bench. Environ Toxicol Chem 31:15-31
30. Handy RD, van den Brink N, Chappell M, Mühling M, Behra R, Dušinská M, et al. 2012a. Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: What have we learnt so far? Ecotoxicology 21(4):933-972
31. Hartung T. 2009. Toxicology for the twenty first century. Nature 460 (7252):208-212
32. Hassellov M, Readman J, Rabville J, Tiede K. 2008. Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles. Ecotoxicology 17:344-361
33. Holloway JW, Savarimuthu Francis S, Fong KM, Yang IA. 2012. Genomics and the respiratory effects of air pollution exposure. Respirology 17(4):590-600
34. Hristozov DR, Gottardo S, Cinelli M, Isigonis P, Zabeo A, Critto A, et al. 2013. Application of a quantitative weight of evidence approach for ranking and prioritising occupational exposure scenarios for titanium dioxide and carbon nanomaterials. Nanotoxicology Epub ahead of print; doi:10.3109/17435390.2012. 760013
35. Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. 2012. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. J Controll Rel 164(3):307-313
36. Johnston H, Pojana G, Zuin S, Jacobsen NR, Møller P, Loft S, et al. 2013. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: Potential solutions to current and future challenges. Crit Rev Toxicol 43(1):1-20
37. Klaine SJ, Alvarez PJ, Batley GE, Fernandes TF, Handy RD, Lyon DY, et al. 2008. Nanomaterials in the environment: Behavior, fate, bioavailability, and effects. Environ Toxicol Chem 27(9):1825- 1851
38. Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. 2012. Hazard identification of inhaled nanomaterials: Making use of short-Term inhalation studies. Arch Toxicol 86 (7):1137-1151
39. Koturbash I, Simpson NE, Beland FA, Pogribny IP. 2012. Alterations in histone H4 lysine 20 methylation: Implications for cancer detection and prevention. Antioxid Redox Signal 17(2):365-374
40. Krug HF, Wick P. 2011. Nanotoxicology: An interdisciplinary challenge. Angew Chem Int Ed Engl 50:1260-1278
41. Kühnel D, Scheffler K, Wellner P, Meißner T, Potthoff A, Busch W, et al. 2012. Comparative evaluation of particle properties, formation of reactive oxygen species and genotoxic potential of tungsten carbide based nanoparticles in vitro. J Hazard Mat 227-228:418-426
42. Lai ZW, Yan Y, Caruso F, Nice EC. 2012. Emerging techniques in proteomics for probing nano-bio interactions. ACS Nano 6 (12):10438-10448
43. Landsiedel R, Fabian E, Ma-Hock L, Wohlleben W, Wiench K, Oesch F, et al. 2012. Toxico-/biokinetics of nanomaterials. Arch Toxicol 86(7):1021-1060
44. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F. 2009. Genotoxicity investigations on nanomaterials: Methods, preparation and characterization of test material, potential artifacts and limitations - many questions, some answers. Mutat Res 681(2-3):241-258
45. Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, et al. 2010. Testing metal-oxide nanomaterials for human safety. Adv Mat 22:2601-2627
46. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350-8361
47. Leonard F, Ali H, Collnot E-M, Crielaard BJ, Lammers T, Storm G, et al. 2012. Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. ALTEX 29(3):275-285
48. Liu J, Legros S, Ma G, Veinot JG, von der Kammer F, Hofmann T. 2012. Influence of surface functionalization and particle size on the aggregation kinetics of engineered nanoparticles. Chemosphere 87(8):918-924
49. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, et al. 2011. The evolution of the protein corona around nanoparticles: A test study. ACS Nano 5:7503-7509
50. Lynch AM, Sasaki JC, Elespuru R, Jacobson-Kram D, Thybaud V, De Boeck M, et al. 2011. New and emerging technologies for genetic toxicity testing. Environ Mol Mutagen 52(3):205-223
51. Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, van Ravenzwaay B, et al. 2009. Development of a short-Term inhalation test in the rat using nano titanium dioxide as a model substance. Inhal Toxicol 21:102-118
52. NanoSafety Cluster. 2011. Nanosafety 2015-2020: A Strategic Research Agenda towards safe and sustainable nanomaterial and nanotechnology innovations. Identified key-Areas of nanosafety research and expected and necessary achievements in these areas by 2015-2020. 37. http://www.nanosafetycluster.eu/ intranet/intra
53. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nanobio interface. Nat Mater 8(7):543-557
54. Nel AE, Xia T, Meng H, Wang X, Lin S, Ji Z, et al. 2013. Nanomaterial toxicity testing in the 21st century: Use of a predictive toxicological approach and high-Throughput screening. Acc Chem Res 46 (3):607-621
55. Oberdörster G. 2009. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J Int Med 267(1):89-105
56. OECD. 2010. Guidance manual for the testing of manufactured nanomaterials: OECD's sponsorship programme; first revision. ENV/JM-MONO(2009)20/REV, OECD; 2 June 2010; Paris, France
57. OECD. 2011. A steering group 7 case-study for hazard identification of inhaled nanomaterials: An integrated approach with short-Term inhalation studies. ENV/CHEM/NANO(2011)6/REV1. 10th Meeting of the Working Party on Manufactured Nanomaterials, OECD; 27-29 June 2012; Paris, France
58. OECD. 2012. Proposal for a template, and guidance on developing and assessing the completeness of adverse outcome pathways. 17. http://www.oecd.org/ env/ehs/testing/49963554.pdf
59. OECD. 2013. Revised Draft Recommendation of the Council on the safety testing and assessment of manufactured nanomaterials. ENV/ CHEM/NANO(2013)3/REV1 Working Party on Manufactured Nanomaterials. OECD; 25 February 2013; Paris, France
60. Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, et al. 2012. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle- induced immunomodulatory effects. Part Fibre Toxicol 8(1):8
61. Peters R, Kramer E, Oomen AG, Rivera ZE, Oegema G, Tromp PC, et al. 2012. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano 6(3):2441-2451
62. RIP-oN 1. 2011. European Commission REACH Implementation Project. Substance Identification of Nanomaterials. AA N-070307/2009/ DI/534733 between DG ENV and JRC. Advisory report, March 2011. http://ec.europa.eu/environment/ chemicals/nanotech/pdf/report- ripon1.pdf. RIP-oN 2. 2011
63. Hankin SM, Peters SAK, Poland CA, Foss Hansen S, Holmqvist J, Ross BL, et al. 2011. Specific advice on fulfilling information requirements for nanomaterials under Reach (RIP-oN 2) - final project report. Reach-Nano consultation. RNC/RIP-oN2/ FPR/1/Final. http://ec.europa.eu/environment/ chemicals/nanotech/ pdf/report-ripon2.pdf
64. Rossini GP, Hartung T. 2012. Food for thought. Towards tailored assays for cell based approaches to toxicity testing. ALTEX 29:359-372
65. Rothen-Rutishauser B, Brown DM, Piallier-Boyles M, Kinloch IA, Windle AH, Gehr P, et al. 2010. Relating the physicochemical characteristics and dispersion of multiwalled carbon nanotubes in different suspension media to their oxidative reactivity in vitro and inflammation in vivo. Nanotoxicol 4(3):331-342
66. Russell WMS, Burch RL. 1959. The principles of humane experimental technique. London, UK: Methuen; Reprinted by UFAW, 1992, 238 pp., 8 Hamilton Close, South Mimms, Potters Bar, Herts EN6 3QD England
67. SCENIHR. 2009. The Scientific committee on emerging and newly identified health risks opinion on risk assessment of products of nanotechnologies. 19 January 2009. http://ec.europa.eu/health/archive/ph-risk/committees/04-scenihr/ docs/scenihr-o-023.pdf
68. Schulze C, Kroll A, Lehr C, Schäfer U.F, Becker K, Schnekenburger J, et al. 2008. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicol 2(2):51-61
69. Silbergeld EK, Contreras EQ, Hartung T, Hirsch C, Hogberg H, Jachak AC, et al. 2011; tt workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials. ALTEX 28 (3):236-241
70. Som C, Nowack B, Krug HF, Wick P. 2012. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials. Acc Chem Res epub ahead of print; doi: 10.1021/ar3000458
71. Stoccoro A, Karlsson HL, Coppedè F, Migliore L. 2012. Epigenetic effects of nano-sized materials. Toxicol Epub ahead of print; doi: Pii: S0300-483X(12)00421-0
72. Stone V, Nowack B, Baun A, van den Brink N, von der Kammer F, Dusinska M, et al. 2010. Nanomaterials for environmental studies: Classification, reference material issues, and strategies for physicochemical characterisation. Sci Total Env 408(7):1745-1754
73. Szyf M. 2011. The implications of DNA methylation for toxicology: Toward toxicomethylomics, the toxicology of DNA methylation. Toxicol Sci 120(2):235-255
74. Tiede K, Boxal A, Tear A, Lewis J, David H, Hassellov M. 2008. Detection and characterization of engineered nanoparticles in food and the environment. Food Addit Contam 25:795-821
75. van Leeuwen CJ, Patlewicz GY, Worth AP. 2007. Intelligent testing strategies. In: Van Leeuwen CJ, Vermeire TG, Vermeire T, editors. Risk assessment of chemicals: An introduction. Heidelberg, Germany: Springer. 467-509
76. Von Der Kammer F, Ferguson PL, Holden PA, Masion A, Rogers KR, Klaine SJ, et al. 2012. Analysis of engineered nanomaterials in complex matrices (environment and biota): General considerations and conceptual case studies. Environ Toxicol Chem 31(1):32-49
77. Zuin S, Micheletti C, Critto A, Pojana G, Johnston H, Stone V, et al. 2011. Weight of evidence approach for the relative hazard ranking of nanomaterials. Nanotoxicol 5(3):445-458